P-291 Retrospective comparison efficacy and toxicity FOLFIRI plus aflibercept or bevacizumab in patients with metastatic colorectal cancer: Results of the multicenter observational study

Autor: Fedyanin, M., Chubenko, V., Belonogov, A., Beluhin, S., Vladimirova, L., Zhabina, A., Kudryavtseva, A., Moiseenko, F., Khasanova, A., Musaeva, H., Novikova, O., Stradaeva, I., Mukhametshina, G., Orlova, R., Micshenko, A., Popova, I., Lyadova, M., Popova, A., Bolotina, L., Kertiev, B., Kuzmina, E., Tjulandin, S.
Zdroj: In Annals of Oncology July 2020 31 Supplement 3:S184-S185
Databáze: ScienceDirect